0.00Open0.96Pre Close0 Volume1 Open Interest970.00Strike Price0.00Turnover8120.97%IV26.16%PremiumJan 3, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.96Extrinsic Value100Contract SizeAmericanOptions Type0.0297Delta0.0008Gamma801.69Leverage Ratio-3984.7087Theta0.0000Rho23.81Eff Leverage0.0007Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet